terferol: from Streptomyces showdoensis SANK 65080; structure given in second source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 167947 |
| CHEMBL ID | 496052 |
| MeSH ID | M0120700 |
| Synonym |
|---|
| 20958-04-7 |
| ACON0_000992 |
| ACON1_001082 |
| MEGXM0_000229 |
| 5'-methoxy-(p-terphenyl)-2',3'-diol |
| (p-terphenyl)-2',3'-diol, 5'-methoxy- |
| brn 3062015 |
| terferol |
| (1,1':4',1''-terphenyl)-2',3'-diol, 5'-methoxy- |
| NCGC00169694-01 |
| CHEMBL496052 |
| 4-methoxy-3,6-diphenylbenzene-1,2-diol |
| 2~5~-methoxy[1~1~,2~1~:2~4~,3~1~-terphenyl]-2~2~,2~3~-diol |
| DTXSID00943246 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID733965 | Inhibition of cGMP-PDE (unknown origin) | 2013 | Journal of natural products, Mar-22, Volume: 76, Issue:3 | Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the order Chaetothyriales (MSX 47445). |
| AID376631 | Antiparasitic activity against Toxoplasma gondii in human foreskin fibroblast by beta-galactosidase assay | 2006 | Journal of natural products, Apr, Volume: 69, Issue:4 | Highly substituted terphenyls as inhibitors of parasite cGMP-dependent protein kinase activity. |
| AID376630 | Inhibition of Eimeria tenella cAMP-dependent protein kinase assessed as inhibition of transfer of phosphate group by radiometric assay | 2006 | Journal of natural products, Apr, Volume: 69, Issue:4 | Highly substituted terphenyls as inhibitors of parasite cGMP-dependent protein kinase activity. |
| AID733966 | Inhibition of cAMP-PDE (unknown origin) | 2013 | Journal of natural products, Mar-22, Volume: 76, Issue:3 | Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the order Chaetothyriales (MSX 47445). |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.80) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||